| Edit |   |
|---|
| Antigenic Specificity | Nuclear Receptor NR4A1 |
|---|
| Clone | polyclonal |
|---|
| Host Species | Rabbit |
|---|
| Reactive Species | human, mouse, rat |
|---|
| Isotype | n/a |
|---|
| Format | peptide affinity purified |
|---|
| Size | 0.1 mg |
|---|
| Concentration | n/a |
|---|
| Applications | Immunohistochemistry (IHC), ELISA (EIA) |
|---|
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
|---|
| Description | Nuclear Receptor NR4A1 (Phospho-Ser351) Antibody. Specificity: Nuclear Receptor NR4A1 (Phospho-Ser351) antibody detects endogenous levels of Nuclear Receptor NR4A1 only when phosphorylated at serine 351. |
|---|
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Nuclear Receptor NR4A1 around the phosphorylation site of serine 351 (L-P-SP-K-P).All Sites: Human: Ser351; Mouse: Ser354; Rat: Ser350Pathway: Phospho-specific |
|---|
| Other Names | nuclear receptor subfamily 4 group A member 1 isoform 2; Nuclear receptor subfamily 4 group A member 1; nuclear receptor subfamily 4 group A member 1; ST-59; hormone receptor; TR3 orphan receptor; steroid receptor TR3; testicular receptor 3; early response protein NAK1; orphan nuclear receptor HMR; orphan nuclear receptor TR3; nuclear hormone receptor NUR/77; growth factor-inducible nuclear protein N10; nerve growth factor IB nuclear receptor variant 1; nuclear receptor subfamily 4, group A, mem |
|---|
| Gene, Accession # | Gene ID: 3164, NCBI: NP_001189162.1, UniProt: P22736 |
|---|
| Catalog # | MBS853492 |
|---|
| Price | |
|---|
| Order / More Info | Nuclear Receptor NR4A1 Antibody from MYBIOSOURCE INC. |
|---|
| Product Specific References | Nakai A., Mol. Endocrinol. 4:1438-1443(1990). Chang C., J. Steroid Biochem. 34:391-395(1989). Bondy G.P., Cell Growth Differ. 2:203-208(1991). - --------------------------------------------------------------------------------------------------------------------------------------------------------------- |
|---|